Dr. Goldenberg was named director of research at Johns Hopkins All Children's Hospital in July 2012 as well as chief research officer of the All Children's Research Institute and director of the new Clinical and Translational Research Organization at Johns Hopkins All Children's Hospital. He is a professor of pediatrics and medicine at the Johns Hopkins University School of Medicine, and an international leader in the field of venous thromboembolism in children and young adults.
Dr. Goldenberg is overall principal investigator for the National Institutes of Health (NIH)-sponsored Kids-DOTT trial, a multinational randomized controlled trial investigating the optimal duration of anticoagulation (anti-clotting medication) for venous thromboembolism (blood clots in the veins) in patients under 21 years of age. He also serves as principal investigator for two large Hopkins pediatric precision medicine studies being conducted at Johns Hopkins All Children’s Hospital (JHACH, St. Petersburg, FL) and the Johns Hopkins Children’s Center and Bayview campuses (Baltimore, MD): iPICS (Institution-wide Prospective Inception Cohort Study of Individuals with Childhood-Onset Acute and Chronic Health Conditions) and the PREDICT birth cohort study (Prospective Research on Early Determinants of Illness and Children's Health Trajectories). The key aims of these longitudinal cohort studies with parallel biobanking are to discover early determinants of disease incidence and disease outcomes and to develop predictive models involving clinical, genetic, epigenetic, and social/environmental factors that will lead to earlier diagnosis and improved treatments in the future.
In addition to these study leadership roles, Dr. Goldenberg chairs or serves as a member of steering committees and data and safety monitoring committees for several NIH- and pharmaceutical industry-sponsored multicenter clinical trials, and has co-authored numerous international clinical and clinical research guidelines in pediatric thrombosis and stroke. He directs the Johns Hopkins Pediatric Thrombosis Program spanning the FL and MD campuses, and also directs the Pediatric Stroke Program at JHACH.
Dr. Goldenberg has authored over 120 original research reports, review articles, and book chapters, mostly as first or senior author. He is also the co-editor of a definitive textbook from Cambridge University Press on pediatric thrombotic disorders.
Prior to joining Hopkins, Dr. Goldenberg was on the faculty of the University of Colorado School of Medicine and served as director of the Children's Clinical Research Organization and co-director of the pediatric thrombosis and stroke programs at Children's Hospital Colorado. He also directed the Department of Clinical Science and Safety at CPC Clinical Research, a university-affiliated Academic Research Organization that runs NIH- and pharma-sponsored clinical trials. Dr. Goldenberg holds a Ph.D. in Clinical Investigation from the University of Colorado.